Oral Appliance in Obstructive Sleep Apnea. A Randomized Controlled Blinded Multicenter Study Comparing Two Devices

November 6, 2017 updated by: Uppsala University

Oral Appliance in the Treatment of Obstructive Sleep Apnea. A Randomized Controlled Blinded Multicenter Study Comparing the Efficacy of Two Devices

The hypothesis of the study is that a bibloc-apnea splint has a comparable efficacy on respiratory measures as a monobloc-apnea splint and that the cost of treatment is the same. The goal is primarily to compare the Apnea-Hypopnea Index (AHI) after 6 weeks of treatment and the cost of treatment during one year.

This randomized controlled parallel group multicenter study includes 316 subjects referred for the treatment of moderate to severe Obstructive Sleep Apnea (OSA). The subjects visit the clinic at 5 scheduled occasions.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study includes 2 arms. Secondary measures are obtained by respiratory analysis and questionnaires. Electromyography (EMG) of the masseter muscle is recorded and the influence of bruxism is evaluated in terms effect on efficacy and adverse events

Study Type

Interventional

Enrollment (Actual)

313

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Örebro, Sweden, 70111
        • Postgraduate Dental Education Center
    • Västmanland
      • Västerås, Västmanland, Sweden, 72189
        • Västmanland County Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The diagnosis of obstructive sleep apnea with AHI > 15
  • Odontological status that allows retention of oral devices and with at least one molar in each quadrant
  • Maximal protrusion >6 mm
  • Subject giving his/her informed concent
  • Understands and can communicate in Swedish
  • Subject understands the instruction on how to put on the polygraphy equipment at home
  • Valid AHI data at baseline respiratory analysis

Exclusion Criteria:

  • age< 18 år
  • BMI >35
  • Jaw complaints requiring treatment the past year
  • Pain or locking of the jaw at the enrollment visit
  • At the discretion of the investigator judged not being able to attach to the study directives
  • Hypersensitive to the material of the devices
  • Ongoing Continuous Positive Airway Pressure (CPAP) treatment or oral device treatment or such treatment terminated within a month from enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Monobloc
Treatment with an appliance that holds the lower jaw in a fixed protruded position
Construction fitted to upper and lower jaw
Other Names:
  • Mandibular protruding device
Active Comparator: Bibloc
Bibloc device where a maxillary splint is connected to a mandibular splint by a connector allowing a slight opening of the jaw without compromizing the protrusion (Narval)
Biblock construction
Other Names:
  • Narval

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Apnoea-Hypopnea-Index (AHI)
Time Frame: 9 weeks after start of study
AHI defined by American Academy of Sleep Medicine (AASM)
9 weeks after start of study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen Desaturation Index (ODI)
Time Frame: 9 weeks
Number of episodes per hour with arterial oxygen saturation decline of 3% or more
9 weeks
Sleepiness
Time Frame: 9 weeks and 1 year
Epworth Sleepiness Scale (ESS)
9 weeks and 1 year
Quality of life
Time Frame: 9 weeks and 1 year
Functional Outcomes of Sleep Questionnaire (FOSQ )
9 weeks and 1 year
Sleep bruxism
Time Frame: 9 weeks
Bruxism episodes during sleep
9 weeks
Adverse events
Time Frame: 1 year
Subject reported and objective investigator observed events
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost of care
Time Frame: 1 year
Total cost calculation including the device, repairs and adjustments and consumption of dentist time
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Goran Isacsson, assoc prof, Västmanlands County hospital Västerås, Sweden

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 15, 2017

Study Registration Dates

First Submitted

May 16, 2014

First Submitted That Met QC Criteria

May 22, 2014

First Posted (Estimate)

May 28, 2014

Study Record Updates

Last Update Posted (Actual)

November 8, 2017

Last Update Submitted That Met QC Criteria

November 6, 2017

Last Verified

November 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstructive Sleep Apnea

Clinical Trials on Monobloc

3
Subscribe